Trade Tecan Group Ltd - TECN CFD

Trading Conditions

• Spread: 1.8
• Long position overnight feeLong position overnight feeMargin. Your investmentCHF 1,000.00Overnight feeCharges from full value of position-0.014982 %(-CHF 0.60)Trade size with leverage ~ CHF 5,000.00Short position overnight fee ~ CHF 4,000.00Go to platform: -0.014982%
• Short position overnight feeShort position overnight feeMargin. Your investmentCHF 1,000.00Overnight feeCharges from full value of position-0.00724 %(-CHF 0.30)Trade size with leverage ~ CHF 5,000.00Short position overnight fee ~ CHF 4,000.00Go to platform: -0.00724%
• Overnight fee time: 21:00 (UTC)
• Currency: CHF
• Min traded quantity: 1
• Margin: 20
• Stock exchange: Switzerland
• Commission on trade: 0%

• Margin. Your investment: CHF 1,000.00
• Overnight feeCharges from full value of position: -0.014982 %
  (-CHF 0.60)

• Margin. Your investment: CHF 1,000.00
• Overnight feeCharges from full value of position: -0.00724 %
  (-CHF 0.30)

Key Stats

• Prev. Close: 332.9
• Open: 322.7
• 1-Year Change: -16.81%
• Day's Range: 322.7 - 329.7

Tecan Company profile

About Tecan Group AG

Tecan Group AG is a Switzerland-based company engaged in the development, production and distribution of advanced automation and detection solutions for the life science laboratories. Its product portfolio is diversified into several product groups. The Liquid Handling & Robotics group encompasses laboratory technologies for safety, among others. The Reader & Washer product group covers micro plate instruments. The Microarray Products group includes microarray scanner and automated hybridization station. The HP D300 Digital Dispenser and Sample Management product groups cover systems for automated management of sample libraries. The Components group covers the supply services of products for laboratory automation instruments. The OEM (original equipment manufacturing) product group covers platform-based systems, systems from scratch and Cavro OEM Components. The Company also offers packaged software and consumables through Software and Consumables product groups, respectively.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Tecan Group AG revenues increased 30% to SF946.6M. Net income increased 17% to SF121.7M. Revenues reflect Partnering Business segment increase of 43% to SF461.6M, Life Sciences Business segment increase of 19% to SF485.1M, America segment increase of 36% to SF437.2M, Europe (excluding Switzerland) segment increase of 27% to SF346.4M, Asia segment increase of 23% to SF149.7M.

Equity composition

07/2007, Capital repayment of CHF 0.45 and nominal value changed from CHF 1.